title: Effectiveness of sodium hydroxide as a pleural sclerosing agent in rabbits: influence of concomitant intrapleural lidocaine.
abstract: The two agents that have been used most commonly to produce a pleurodesis are tetracycline and bleomycin. Tetracycline is no longer generally available because of more stringent requirements on the manufacturing process. Bleomycin is very expensive. Therefore, alternative agents are necessary particularly in developing countries. The objective of this project was to determine whether 0.5% sodium hydroxide is an effective sclerosant in an experimental model in rabbits. Sodium hydroxide (NaOH) (2 ml of 0.5%) was instilled intrapleurally in 24 anesthetized male rabbits. Half the rabbits received 1 ml of 2% lidocaine 3-5 min before the NaOH. Twenty-eight days after the instillation, the animals were sacrificed, and the pleural spaces were assessed grossly for evidence of pleurodesis and microscopically for evidence of fibrosis and inflammation. The results indicated that the intrapleural injection of NaOH was effective in creating a pleurodesis only if the animals were not premedicated with lidocaine. The mean (+/- S.D.) degree of gross pleurodesis after NaOH alone 2.8 (1.0) was significantly (p < 0.001) greater than after that following the combination 1.3 (0.5). We conclude that NaOH is an effective pleural sclerosant but that it is ineffective if it is injected concomitantly with lidocaine.
authors.affiliation: Instituto do Coracao, Faculty of Medicine, University of Sao Paulo, Brazil.
authors.forename: L R
authors.initials: LR
authors.lastname: Teixeira
authors.forename: F S
authors.initials: FS
authors.lastname: Vargas
authors.forename: A O
authors.initials: AO
authors.lastname: Carmo
authors.forename: A
authors.initials: A
authors.lastname: Cukier
authors.forename: L M
authors.initials: LM
authors.lastname: Silva
authors.forename: R W
authors.initials: RW
authors.lastname: Light
mesh_terms: D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D002424:Caustics / Q000494:pharmacology*; D005355:Fibrosis / Q000139:chemically induced / Q000473:pathology; D005500:Follow-Up Studies; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D010994:Pleura / Q000187:drug effects* / Q000473:pathology; D018700:Pleurodesis / Q000379:methods*; D011817:Rabbits; D012597:Sclerosing Solutions / Q000494:pharmacology*; D012972:Sodium Hydroxide / Q000494:pharmacology*
chemical_list: D000779:Anesthetics, Local; D002424:Caustics; D012597:Sclerosing Solutions; D012972:Sodium Hydroxide; D008012:Lidocaine